Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 6516
Affinity DataIC50: 12.2nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
Affinity DataIC50: 24.8nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
Affinity DataIC50: 27.5nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 118nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
Affinity DataIC50: 139nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 176nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
Affinity DataIC50: 201nMAssay Description:Inhibition of C-kit kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrate in ...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 316nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 363nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 479nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
TargetPlatelet-derived growth factor receptor beta(Human)
Development Center For Biotechnology
US Patent
Development Center For Biotechnology
US Patent
Affinity DataIC50: 859nMpH: 7.0Assay Description:Inhibition of PDGFR-beta kinase activity by compounds disclosed herein was quantified by measuring the amount of [33P] incorporated into the substrat...More data for this Ligand-Target Pair
